Manage episode 282212844 series 2847785
The start of 2021 hasn't brought much relief when it comes to COVID-19. Cases are exploding, hospitalizations are rising and deaths are climbing. The light at the end of this dark tunnel, however, is the rollout of vaccines. So far Pfizer and Moderna have received emergency approval and distributed vaccines in the U.S., but it's been slow going. There is, however, another major player that will be joining the fight with a new vaccine. Johnson and Johnson is about to release findings on its phase three clinical trial by the end of January and if all goes well, the one-dose vaccine will be released as early as February. 45-thousand people took part in the phase three clinical trial and May was one of them. She volunteered back in December to help the cause, especially because people of color are often underrepresented in vaccine research. In this episode, May walks us through her experience and talks to Dr. Kenneth Kim of Ark Clinical Research who conducted J&J's trials in Southern California. This is an extremely informative and educational episode!